Sidechain-linked inhibitors of HIV-1 protease dimerization
Michael J Bowman1, Jean Chmielewski
1Department of Chemistry, 560 Oval Drive, Purdue University, West Lafayette, IN 47907, USA.
Abstract:
There is a great need for alternative modes of inhibition for the design of anti-HIV therapies, due to the increased resistance of HIV to currently approved drugs. A novel strategy for generating potent dimerization inhibitors of HIV-1 protease is described based on sidechain-linked interfacial peptides. In a number of cases the activity of these agents against HIV-1 protease was found to be among the most potent reported, with inhibitory constants in the low nM range.
More Related Videos
08:33Nucleocapsid Annealing-Mediated Electrophoresis (NAME) Assay Allows the Rapid Identification of HIV-1 Nucleocapsid Inhibitors
Published on: January 19, 2015
10:17Creating Highly Specific Chemically Induced Protein Dimerization Systems by Stepwise Phage Selection of a Combinatorial Single-Domain Antibody Library
Published on: January 14, 2020
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Ligand Binding and Linkage
Antiviral Nucleoside Inhibitors
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein.
Inhibitors of Viral Protein Synthesis
Protein-protein Interfaces
